Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Abdi İbrahim
AddedFeb 19, 2024
UpdatedJun 28, 2026
Abdi İbrahim

Abdi İbrahim

Leading Turkish pharma company focused on global growth and sustainable leadership.

HQ
Istanbul, Istanbul Province, TR
Founded
1912
Overview
Compare
Employees

Founded in 1912, Abdi İbrahim is a leading Turkish pharmaceutical company committed to global growth and sustainable leadership. The company's core mission is to improve health and quality of life by providing innovative and high-quality pharmaceutical products. Abdi İbrahim's extensive portfolio includes prescription medications, over-the-counter drugs, and healthcare products, serving both domestic and international markets.

Notable figures associated with Abdi İbrahim include its long-standing leadership team, which has driven the company's strategic vision and expansion. The company has achieved significant milestones, such as being the market leader in Turkey and expanding its operations to over 60 countries. Abdi İbrahim's impact is evident in its contributions to healthcare advancements and its commitment to sustainability and corporate social responsibility.

Abdi İbrahim - Similar Companies

Teva Pharmaceutical Industries logo

Teva Pharmaceutical Industries

tevapharm.com

Bayer Pharmaceuticals logo

Bayer Pharmaceuticals

bayer.com

Farmak logo

Farmak

farmak.ua

AbbVie logo

AbbVie

abbvie.com

Novartis Pharma logo

Novartis Pharma

Pharco Pharmaceuticals logo

Pharco Pharmaceuticals

pharco.org

AstraZeneca logo

AstraZeneca

astrazeneca.com

Boehringer Ingelheim logo

Boehringer Ingelheim

Astellas Pharma logo

Astellas Pharma

Adamed Group logo

Adamed Group

adamed.com.pl

Libbs Farmaceutica logo

Libbs Farmaceutica

libbs.com.br

Bayer logo

Bayer

bayer.com

Bristol Myers Squibb logo

Bristol Myers Squibb

bms.com

Kyowa Kirin Co. logo

Kyowa Kirin Co.

kyowakirin.com

Phoenix Pharmahandel logo

Phoenix Pharmahandel

phoenixgroup.eu

Abdi İbrahim - Quick Facts

Who are Abdi İbrahim's competitors?

Companies similar to Abdi İbrahim include Teva Pharmaceutical Industries, Bayer Pharmaceuticals, Farmak and AbbVie.

When was Abdi İbrahim founded?

Abdi İbrahim was founded in 1912.

Where is Abdi İbrahim's headquarters located?

Abdi İbrahim's headquarters is located in Istanbul, Istanbul Province, TR.

How many employees does Abdi İbrahim have?

Abdi İbrahim has 4,337 employees as of Feb 10, 2024.

Abdi İbrahim - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Consumers
Main Product
  • Healthcare
  • Pharmaceuticals
NAICS
  • 330000Manufacturing
SIC
  • 3900Miscellaneous Manufacturing Industries